Cargando…
Effect of stage shift and immunotherapy treatment on lung cancer survival outcomes
OBJECTIVES: Non-small-cell lung cancer mortality has declined at a faster rate than incidence due to multiple factors, including changes in smoking behaviour, early detection which shifts diagnosis, and novel therapies. Limited resources require that we quantify the contribution of early detection v...
Autores principales: | Patel, Parth, Flores, Raja, Alpert, Naomi, Pyenson, Bruce, Taioli, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412408/ https://www.ncbi.nlm.nih.gov/pubmed/37285318 http://dx.doi.org/10.1093/ejcts/ezad203 |
Ejemplares similares
-
Association of Stage Shift and Population Mortality Among Patients With Non–Small Cell Lung Cancer
por: Flores, Raja, et al.
Publicado: (2021) -
Shift in lung cancer stage at diagnosis during the COVID-19 pandemic in New York City
por: Flores, Raja, et al.
Publicado: (2022) -
Association of Personal Characteristics and Effectiveness of Immunotherapy in Late-Stage Non-Small Cell Lung Cancer: A Systematic Review
por: Patel, Krishna, et al.
Publicado: (2022) -
Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer
por: Patel, Krishna H., et al.
Publicado: (2023) -
Surgical markup in lung cancer resection, 2015-2020
por: Robinson, Eric, et al.
Publicado: (2023)